Osimertinib failure followed by successful treatment of afatinib in a patient with compound uncommon, G719S and V834L mutations

• Kohei Isa,
• Kentaro Tanaka,
• Yoshimasa Shiraishi,
• Yasuto Yoneshima,
• Eiji Iwama,
• Isamu Okamoto

Affiliations

Kohei Isa

Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Kentaro Tanaka

Correspondence author.; Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Yoshimasa Shiraishi

Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Yasuto Yoneshima

Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Eiji Iwama

Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Isamu Okamoto

Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan